P1.198. Systematic Screening for Anastomotic Leakage After Esophagectomy for Cancer: Lessons Learned From a Retrospective Analysis
Diseases of the Esophagus · 22.08.2026 · 39 (Supplement_1)
DOI: 10.1093/dote/doag077.346 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diseases of the Esophagus, online erschienen am 22.08.2026. Verfasst von Ward Seurs und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Topic Esophageal Cancer: Surgical Treatment of Esophageal Cancer – early outcomes and complications Background Anastomotic leakage (AL) after esophagectomy for cancer is associated with negative outcomes that could be mitigated by screening and early treatment of the complication. We aimed to assess whether patients with AL diagnosed through systematic radiological screening did already exhibit signs of possible leakage which would have prompted diagnostic testing.
Methods
Patients undergoing esophagectomy with intrathoracic anastomosis at a tertiary center between 2014 and 2021 were included. Systematic screening consisted of contrast swallow or computed tomography (CT) with per-oral contrast on postoperative days (POD) 4–5. Patients with positive screening were assessed for following signs suggestive of AL from POD 0 to POD 5: C-reactive protein (CRP) ≥ 300mg/L, new-onset leukocytosis with white blood cell count ≥ 10*109/L, temperature ≥ 38°C, tachycardia with ≥ 120 bpm, and presence of atrial dysrhythmia.
Results
Of 53 patients with intrathoracic AL, 49 (92.5%) underwent systematic screening and 9 (17.0%) were diagnosed at screening (contrast swallow 55.6%, CT 44.4%). In all these patients with positive screening, signs suggestive of AL were already present: elevated CRP in 2 (22%), new-onset leukocytosis in 3 (33.3%), fever in 6 (66.7%), tachycardia in 6 (66.7%), and atrial dysrhythmia in 1 (11.1%). Of note, the 40 (81.6%) patients with negative screening developed AL on median day 9.5 (interquartile range 7-15.25), despite initial screening being negative.
Conclusion
Although early diagnosis of AL is key to its successful management, systematic screening could only diagnose patients who were already exhibiting symptoms or signs suggestive of leakage. With day of AL-diagnosis varying strongly in our cohort, and screening providing a false sense of security in 81.6% of patients, these results advocate for a more patient-tailored, targeted approach to screening for AL.
Zitieren
APA
Seurs, W., Sousa, I. C. D., Coninck, W. D., Moons, J., Vanstraelen, S., Veer, H. V., Nafteux, P., & Depypere, L. (2026). P1.198. Systematic Screening for Anastomotic Leakage After Esophagectomy for Cancer: Lessons Learned From a Retrospective Analysis. Diseases of the Esophagus, 39(Supplement_1). https://doi.org/10.1093/dote/doag077.346
Vancouver
Seurs W, Sousa ICD, Coninck WD, Moons J, Vanstraelen S, Veer HV, et al. P1.198. Systematic Screening for Anastomotic Leakage After Esophagectomy for Cancer: Lessons Learned From a Retrospective Analysis. Diseases of the Esophagus. 2026;39(Supplement_1). doi:10.1093/dote/doag077.346
BibTeX
@article{Seurs2026,
author = {Seurs, Ward and Sousa, Isabela Camargo De and Coninck, Willem De and Moons, Johnny and Vanstraelen, Stijn and Veer, Hans Van and Nafteux, Philippe and Depypere, Lieven},
title = {P1.198. Systematic Screening for Anastomotic Leakage After Esophagectomy for Cancer: Lessons Learned From a Retrospective Analysis},
journal = {Diseases of the Esophagus},
year = {2026},
volume = {39},
number = {Supplement_1},
doi = {10.1093/dote/doag077.346}
}
EUVIMED